Tirzepatide use lowered risk for diabetic retinopathy incidence and worsening events compared with lifestyle intervention alone.

Risk for nonarteritic anterior ischemic optic neuropathy was more than doubled among patients initiating semaglutide vs SGLT2is.

Paris II and Momah/Lindor biochemical response criteria predict improved transplant-free survival and serve as potential ...

Åsa H. Everhov, M.D., from the Karolinska Institutet in Stockholm, and colleagues evaluated rectal cancer risk in patients ...

Greater weight loss was linked to greater willingness to continue semaglutide use, even when accompanied by gastrointestinal side effects.

More than one-fifth of individuals with HCC experience treatment delays exceeding 90 days, but those delays do not significantly affect overall survival.

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

Zepbound KwikPen, a 4-dose single-patient delivery device for tirzepatide administration has been made available by Lilly.

Metabolic syndrome exacerbates inpatients outcomes and increased health care use among patients hospitalized with IBD.

The FDA proposed new guidelines for approving experimental therapies for rare diseases without large group studies.

Nutrition and lifestyle interventions, including whole-food plant-based diets, show promise in managing mood disorders and ...

Colorectal cancer was more common among patients with inflammatory bowel disease who had high-grade dysplasia.